Gregory Crane
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Treatment and Pharmacology
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- Cancer Treatment and Pharmacology 3
-
- Breast Cancer Treatment Studies 5
- Cancer Genomics and Diagnostics 4
- Co-authors
- Anne O’Dea (11 shared papers)Qamar J. Khan (10 shared papers)Priyanka Sharma (11 shared papers)Jamie L. Wagner (4 shared papers)Lauren Nye (10 shared papers)Joshua M. Staley (8 shared papers)Milind A. Phadnis (4 shared papers)Andrew K. Godwin (9 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (3 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)JAMA Oncology (1 paper)
- Partner nations
- United StatesBelgiumAustralia
In The Last Decade
Gregory Crane
10 papers receiving 218 citations
Gregory Crane's Hit Papers
Peers
Comparison fields: 5 of 27
- Cancer Research 79
- Oncology 136
- Pulmonary and Respiratory Medicine 64
- Immunology 32
- Genetics 9
Countries citing papers authored by Gregory Crane
This map shows the geographic impact of Gregory Crane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Crane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Crane more than expected).
Fields of papers citing papers by Gregory Crane
This network shows the impact of papers produced by Gregory Crane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Crane. The network helps show where Gregory Crane may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory Crane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer Hit paper breakdown → | 2023 | 92 |
| 2 | 2020 | 49 | |
| 3 | 2022 | 38 | |
| 4 | 2021 | 16 | |
| 5 | 2019 | 8 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2025 | 0 |
About Gregory Crane
Gregory Crane is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 11 papers that have together received 219 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Treatment and Pharmacology (3 papers), Advanced Breast Cancer Therapies (3 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Multiple and Secondary Primary Cancers (1 paper) and Advanced Radiotherapy Techniques (1 paper). The work is most often cited by research in Cancer Research (79 citations), Oncology (136 citations), Pulmonary and Respiratory Medicine (64 citations), Immunology (32 citations) and Genetics (9 citations). Gregory Crane has collaborated with scholars based in United States, Belgium and Australia. Frequent co-authors include Anne O’Dea, Qamar J. Khan, Priyanka Sharma, Jamie L. Wagner, Lauren Nye, Joshua M. Staley, Milind A. Phadnis, Andrew K. Godwin, Rachel Yoder and Rashna Madan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, International Journal of Radiation Oncology*Biology*Physics and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.